Works matching AU Herndon II, James E.

Results: 47

Intraoperative brain tumor classification via laser-induced fluorescence spectroscopy and machine learning.

Published in:

Journal of Neurosurgery, 2025, v. 143, n. 2, p. 313, doi. 10.3171/2024.12.JNS242041

By:

Zachem, Tanner J.;
Sperber, Jacob E.;
Chen, Sully F.;
Adil, Syed M.;
Wissel, Benjamin D.;
Chamberlin, Gregory;
Owolo, Edwin;
Nguyen, Annee;
Crowell, Kerri-Anne;
Herndon II, James E.;
Hachem, Ralph Abi;
Jang, David W.;
Cummings, Thomas J.;
Johnson, Margaret O.;
Eward, William;
Patel, Anoop P.;
Komisarow, Jordan M.;
Cook, Steven H.;
Southwell, Derek;
Fecci, Peter E.

Publication type:

Article

Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series.

Published in:

Journal of Neuro-Oncology, 2020, v. 147, n. 2, p. 477, doi. 10.1007/s11060-020-03446-3

By:

Patel, Mallika P.;
Kirkpatrick, John P.;
Johnson, Margaret O.;
Healy, Patrick;
Herndon II, James E.;
Lipp, Eric S.;
Miller, Elizabeth S.;
Desjardins, Annick;
Randazzo, Dina;
Friedman, Henry S.;
Ashley, David M.;
Peters, Katherine B.

Publication type:

Article

Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas.

Published in:

Journal of Neuro-Oncology, 2018, v. 137, n. 2, p. 349, doi. 10.1007/s11060-017-2724-1

By:

Peters, Katherine B.;
Lipp, Eric S.;
Miller, Elizabeth;
Herndon II, James E.;
McSherry, Frances;
Desjardins, Annick;
Reardon, David A.;
Friedman, Henry S.

Publication type:

Article

Systemic Therapy Type and Timing Effects on Radiation Necrosis Risk in HER2+ Breast Cancer Brain Metastases Patients Treated With Stereotactic Radiosurgery.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.854364

By:

Park, Christine;
Buckley, Evan D.;
Van Swearingen, Amanda E. D.;
Giles, Will;
Herndon II, James E.;
Kirkpatrick, John P.;
Anders, Carey K.;
Floyd, Scott R.

Publication type:

Article

Aberrant p53 Staining Does Not Predict Cisplatin Resistance in Locally Advanced Non-Small Cell Lung Cancer.

Published in:

Cancer Investigation, 2002, v. 20, n. 5/6, p. 686, doi. 10.1081/CNV-120003537

By:

Johnson, Elizabeth A.;
Klimstra, David S.;
Herndon II, James E.;
Catalano, Edison;
Canellos, George P.;
Graziano, Stephen L.;
Kern, Jeffrey A.;
Green, Mark R.

Publication type:

Article

Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma.

Published in:

Oncologist, 2018, v. 23, n. 8, p. 889, doi. 10.1634/theoncologist.2018-0149

By:

Affronti, Mary Lou;
Jackman, Jennifer Gamboa;
McSherry, Frances;
Herndon II, James E.;
Massey Jr., Elwood C.;
Lipp, Eric;
Desjardins, Annick;
Friedman, Henry S.;
Vlahovic, Gordana;
Vredenburgh, James;
Peters, Katherine B.

Publication type:

Article

Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma.

Published in:

Oncologist, 2018, v. 23, n. 2, p. 157, doi. 10.1634/theoncologist.2017-0501

By:

Ghiaseddin, Ashley;
Reardon, David;
Massey, Woody;
Mannerino, Alex;
Lipp, Eric S.;
Herndon II, James E.;
McSherry, Frances;
Desjardins, Annick;
Randazzo, Dina;
Friedman, Henry S.;
Peters, Katherine B.

Publication type:

Article

Pre-Exercise Participation Cardiovascular Screening in a Heterogeneous Cohort of Adult Cancer Patients.

Published in:

2014

By:

Kenjale, Aarti A.;
Hornsby, Whitney E.;
Crowgey, Theresa;
Thomas, Samantha;
Herndon Ii, James E.;
Khouri, Michel G.;
Lane, Amy R.;
Bishop, Caroline E.;
Eves, Neil D.;
Peppercorn, Jeffrey;
Douglas, Pamela S.;
Jones, Lee W.

Publication type:

Journal Article

Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma.

Published in:

Neuro-Oncology, 2004, v. 6, n. 2, p. 145, doi. 10.1215/S1152851703000498

By:

Quinn, Jennifer A.;
Reardon, David A.;
Friedman, Allan H.;
Rich, Jeremy N.;
Sampson, John H.;
Vredenburgh, James;
Gururangan, Sridharan;
Provenzale, James M.;
Walker, Amy;
Schweitzer, Holly;
Bigner, Darell D.;
Tourt-Uhlig, Sandra;
Herndon II, James E.;
Affronti, Mary Lou;
Jackson, Susanne;
Allen, Deborah;
Ziegler, Karen;
Bohlin, Cindy;
Lentz, Christy;
Friedman, Henry S.

Publication type:

Article

Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma.

Published in:

Neuro-Oncology, 2004, v. 6, n. 2, p. 134, doi. 10.1215/S1152851703000413

By:

Reardon, David A.;
Quinn, Jennifer A.;
Rich, Jeremy N.;
Gururangan, Sridharan;
Vredenburgh, James;
Sampson, John H.;
Provenzale, James M.;
Walker, Amy;
Badruddoja, Michael;
Tourt-Uhlig, Sandra;
Herndon II, James E.;
Dowell, Jeannette M.;
Affronti, Mary Lou;
Jackson, Susanne;
Allen, Deborah;
Ziegler, Karen;
Silverman, Steven;
Bohlin, Cindy;
Friedman, Allan H.;
Bigner, Darell D.

Publication type:

Article

Long-term safety of combined intracerebral delivery of free gadolinium and targeted chemotherapeutic agent PRX321.

Published in:

Neurological Research, 2010, v. 32, n. 8, p. 810, doi. 10.1179/174367509X12581069052090

By:

Ding, Dale;
Kanaly, Charles W.;
Cummings, Thomas J.;
Herndon II, James E.;
Raghavan, Raghu;
Sampson, John H.

Publication type:

Article

Biomarkers to Help Guide Management of Patients with Pulmonary Nodules.

Published in:

American Journal of Respiratory & Critical Care Medicine, 2013, v. 188, n. 4, p. 461, doi. 10.1164/rccm.201210-1760oc

By:

Pätz Jr, Edward F.;
Campa, Michael J.;
Gottlin, Elizabeth B.;
Trotter, Priscilla R.;
Herndon II, James E.;
Kafader, Don;
Grant, Russell P.;
Eisenberg, Marcia

Publication type:

Article

MRP3: a molecular target for human glioblastomamultiforme immunotherapy.

Published in:

BMC Cancer, 2010, v. 10, p. 468, doi. 10.1186/1471-2407-10-468

By:

Chien-Tsun Kuan;
Wakiya, Kenji;
Herndon, II, James E.;
Lipp, Eric S.;
Pegram, Charles N.;
Riggins, Gregory J.;
Rasheed, Ahmed;
Szafranski, Scott E.;
McLendon, Roger E.;
Wikstrand, Carol J.;
Bigner, Darell D.

Publication type:

Article

Exercise and dietary change after diagnosis and cancer-related symptoms in long-term survivors of breast cancer: CALGB 79804.

Published in:

Psycho-Oncology, 2009, v. 18, n. 2, p. 128, doi. 10.1002/pon.1378

By:

Alfano, Catherine M.;
Day, Jeannette M.;
Katz, Mira L.;
Herndon II, James E.;
Bittoni, Marisa A.;
Oliveri, Jill M.;
Donohue, Kathleen;
Paskett, Electra D.

Publication type:

Article

Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804.

Published in:

Psycho-Oncology, 2008, v. 17, n. 11, p. 1108, doi. 10.1002/pon.1329

By:

Paskett, Electra D.;
Herndon II, James E.;
Day, Jeannette M.;
Stark, Nancy N.;
Winer, Eric P.;
Grubbs, Stephen S.;
Pavy, Michael D.;
Shapiro, Charles L.;
List, Marcy A.;
Hensley, Martee L.;
Naughton, Michelle A.;
Kornblith, Alice B.;
Habin, Karleen R.;
Fleming, Gini F.;
Bittoni, Marisa A.

Publication type:

Article

Novel Human IgG2b/Murine Chimeric Antitenascin Monoclonal Antibody Construct Radiolabeled with 131I and Administered into the Surgically Created Resection Cavity of Patients with Malignant Glioma: Phase I Trial Results.

Published in:

Journal of Nuclear Medicine, 2006, v. 47, n. 6, p. 912

By:

Reardon, David A.;
Quinn, Jennifer A.;
Akabani, Gamal;
Coleman, R. Edward;
Friedman, Allan H.;
Friedman, Henry S.;
Herndon II, James E.;
McLendon, Roger E.;
Pegram, Charles N.;
Provenzale, James M.;
Dowell, Jeannette M.;
Rich, Jeremy N.;
Vredenburgh, James J.;
Desjardins, Annick;
Sampson, John H.;
Gururangan, Sridharan;
Wong, Terence Z.;
Badruddoja, Michael A.;
Xiao-Guang Zhao;
Bigner, Darell D.

Publication type:

Article

Comparing Knowledge and Perceptions of Palliative Care Among Neuro-Oncology Patients, Caregivers, and Providers to a Representative U.S. Sample.

Published in:

American Journal of Hospice & Palliative Medicine, 2025, v. 42, n. 9, p. 862, doi. 10.1177/10499091241280610

By:

Kim, Jung-Young;
Dalton, Juliet C.;
Cort, Nicole;
Herndon II, James E.;
Affronti, Mary L.;
Peters, Katherine B.;
Jones, Christopher A.;
Johnson, Margaret O.

Publication type:

Article

Comparison of performance status with peak oxygen consumption in operable patients with non-small-cell lung cancer.

Published in:

Respirology, 2014, v. 19, n. 1, p. 105, doi. 10.1111/resp.12162

By:

Roman, Michael A.;
Koelwyn, Graeme J.;
Eves, Neil D.;
Hornsby, Whitney E.;
Watson, Dorothy;
Herndon II, James E.;
Kohman, Leslie;
Loewen, Gregory;
Jones, Lee W.

Publication type:

Article

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy.

Published in:

Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20469-6

By:

Gromeier, Matthias;
Brown, Michael C.;
Zhang, Gao;
Lin, Xiang;
Chen, Yeqing;
Wei, Zhi;
Beaubier, Nike;
Yan, Hai;
He, Yiping;
Desjardins, Annick;
Herndon II, James E.;
Varn, Frederick S.;
Verhaak, Roel G.;
Zhao, Junfei;
Bolognesi, Dani P.;
Friedman, Allan H.;
Friedman, Henry S.;
McSherry, Frances;
Muscat, Andrea M.;
Lipp, Eric S.

Publication type:

Article

Overall Survival of Newly Diagnosed Glioblastoma Patients Receiving Carmustine Wafers Followed by Radiation and Concurrent Temozolomide Plus Rotational Multiagent Chemotherapy.

Published in:

Cancer (0008543X), 2009, v. 115, n. 15, p. 3501, doi. 10.1002/cncr.24398

By:

Affronti, Mary Lou;
Heery, Christopher R.;
Herndon, II, James E.;
Rich, Jeremy N.;
Reardon, David A.;
Desjardins, Annick;
Vredenburgh, James J.;
Friedman, Allan H.;
Bigner, Darell D.;
Friedman, Henry S.

Publication type:

Article

Phase 1 Trial of Temozolomide Plus Irinotecan Plus O6-Benzylguanine in Adults With Recurrent Malignant Glioma.

Published in:

Cancer (0008543X), 2009, v. 115, n. 13, p. 2964, doi. 10.1002/cncr.24336

By:

Quinn, Jennifer A.;
Jiang, Sara Xiaoyin;
Reardon, David A.;
Desjardins, Annick;
Vredenburgh, James J.;
Gururangan, Sridharan;
Sampson, John H.;
McLendon, Roger E.;
Herndon II, James E.;
Friedman, Henry S.

Publication type:

Article

Cancer Surveillance Behaviors and Psychosocial Factors Among Long- Term Survivors of Breast Cancer.

Published in:

Cancer (0008543X), 2009, v. 115, n. 3, p. 480, doi. 10.1002/cncr.24063

By:

Katz, Mira L.;
Donohue, Kathleen A.;
Alfano, Catherine M.;
Day, Jeannette M.;
Herndon, II, James E.;
Paskett, Electra D.

Publication type:

Article

Haptoglobin and Posttranslational Glycan-Modified Derivatives as Serum Biomarkers for the Diagnosis of Nonsmall Cell Lung Cancer.

Published in:

Cancer (0008543X), 2007, v. 110, n. 10, p. 2260, doi. 10.1002/cncr.23049

By:

Hoagland, Luke F. M.;
Campa, Michael J.;
Gottlin, Elizabeth B.;
Herndon II, James E.;
Patz Jr., Edward F.

Publication type:

Article

A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma.

Published in:

Journal of Neurosurgery, 2014, v. 121, n. 3, p. 536, doi. 10.3171/2014.4.JNS121952

By:

KANALY, CHARLES W.;
MEHTA, ANKIT I.;
DING, DALE;
HOANG, JENNY K.;
KRANZ, PETER G.;
HERNDON II, JAMES E.;
COAN, APRIL;
CROCKER, IAN;
WALLER, ANTHONY F.;
FRIEDMAN, ALLAN H.;
REARDON, DAVID A.;
SAMPSON, JOHN H.

Publication type:

Article

SEER insights.

Published in:

Journal of Neurosurgery, 2014, v. 120, n. 2, p. 297, doi. 10.3171/2013.6.JNS13993

By:

SAMPSON, JOHN H.;
LAD, SHIVANAND P.;
HERNDON II, JAMES E.;
STARKE, ROBERT M.;
KONDZIOLKA, DOUGLAS

Publication type:

Article

Subarachnoid hemorrhage trials.

Published in:

Journal of Neurosurgery, 2013, v. 118, n. 1, p. 1, doi. 10.3171/2012.5.JNS12730

By:

ZOMORODI, ALI;
HERNDON II, JAMES E.;
SAMPSON, JOHN H.

Publication type:

Article

Clinical data simplified.

Published in:

Journal of Neurosurgery, 2012, v. 116, n. 2, p. 346

By:

Sampson, John H.;
Herndon II, James E.;
McLendon, Roger E.;
Hasselblad, Vic;
Asher, Anthony L.;
McGirt, Matthew J.;
Peterson, Eric D.

Publication type:

Article

Epidemiology.

Published in:

Journal of Neurosurgery, 2011, v. 115, n. 2, p. 256, doi. 10.3171/2011.1.jns102066

By:

SAMPSON, JOHN H.;
HERNDON II, JAMES E.;
FRIEDMAN, ALLAN H.;
ABERNETHY, AMY P.

Publication type:

Article

Brain metastasis as the first and only metastatic relapse site portends worse survival in patients with advanced HER2 + breast cancer.

Published in:

Breast Cancer Research & Treatment, 2023, v. 197, n. 2, p. 425, doi. 10.1007/s10549-022-06799-7

By:

Noteware, Laura;
Broadwater, Gloria;
Dalal, Nicole;
Alder, Laura;
Herndon II, James E.;
Floyd, Scott;
Giles, William;
Van Swearingen, Amanda E. D.;
Anders, Carey K.;
Sammons, Sarah

Publication type:

Article

Phase II Study of Dasatinib in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer.

Published in:

2017

By:

Kelley, Michael J.;
Jha, Gautam;
Shoemaker, Debra;
Herndon II, James E.;
Gu, Lin;
Barry, William T.;
Crawford, Jeffrey;
Ready, Neal

Publication type:

journal article

A Phase I Study of Dose-Dense Topotecan Given Upfront to Standard Therapy in Patients with Small Cell Lung Cancer.

Published in:

Clinical Drug Investigation, 2006, v. 26, n. 5, p. 257, doi. 10.2165/00044011-200626050-00003

By:

Garst, Jennifer;
Herndon II, James E.;
Shafman, Timothy;
Campagna, Lara;
Blackwell, Susan;
Padilla, Karen;
Bjurstrom, Toni;
Andrews, Carolyn;
Maravich-May, Diana;
Anderson, Elizabeth;
Crawford, Jeffrey

Publication type:

Article

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.

Published in:

Nature, 2015, v. 519, n. 7543, p. 366, doi. 10.1038/nature14320

By:

Mitchell, Duane A.;
Batich, Kristen A.;
Gunn, Michael D.;
Huang, Min-Nung;
Sanchez-Perez, Luis;
Nair, Smita K.;
Congdon, Kendra L.;
Reap, Elizabeth A.;
Archer, Gary E.;
Desjardins, Annick;
Friedman, Allan H.;
Friedman, Henry S.;
Herndon II, James E.;
Coan, April;
McLendon, Roger E.;
Reardon, David A.;
Vredenburgh, James J.;
Bigner, Darell D.;
Sampson, John H.

Publication type:

Article

A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope.

Published in:

NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-020-00273-5

By:

Swartz, Adam M.;
Congdon, Kendra L.;
Nair, Smita K.;
Li, Qi-Jing;
Herndon II, James E.;
Suryadevara, Carter M.;
Riccione, Katherine A.;
Archer, Gary E.;
Norberg, Pamela K.;
Sanchez-Perez, Luis A.;
Sampson, John H.

Publication type:

Article

Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models.

Published in:

Science Translational Medicine, 2023, v. 15, n. 682, p. 1, doi. 10.1126/scitranslmed.abn5649

By:

Parker, Scott;
McDowall, Charlotte;
Sanchez-Perez, Luis;
Osorio, Cristina;
Duncker, Patrick C.;
Briley, Aaron;
Swartz, Adam M.;
Herndon II, James E.;
Yu, Yen-Rei A.;
McLendon, Roger E.;
Tedder, Thomas F.;
Desjardins, Annick;
Ashley, David M.;
Gunn, Michael Dee;
Enterline, David S.;
Knorr, David A.;
Pastan, Ira H.;
Nair, Smita K.;
Bigner, Darell D.;
Chandramohan, Vidyalakshmi

Publication type:

Article

Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trial.

Published in:

Supportive Care in Cancer, 2022, v. 30, n. 4, p. 3463, doi. 10.1007/s00520-021-06738-0

By:

Peters, Katherine B.;
Affronti, Mary L.;
Woodring, Sarah;
Lipp, Eric;
Healy, Patrick;
Herndon II, James E.;
Miller, Elizabeth S.;
Freeman, Maria W.;
Randazzo, Dina M.;
Desjardins, Annick;
Friedman, Henry S.

Publication type:

Article

Response to the letter to the Editor concerning manuscript entitled, "Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide"

Published in:

2020

By:

Affronti, Mary Lou;
Herndon II, James E.;
Patel, Mallika P.

Publication type:

Letter

Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide.

Published in:

2020

By:

Patel, Mallika P.;
Woodring, Sarah;
Randazzo, Dina M.;
Friedman, Henry S.;
Desjardins, Annick;
Healy, Patrick;
Herndon II, James E.;
McSherry, Frances;
Lipp, Eric S.;
Miller, Elizabeth;
Peters, Katherine B.;
Affronti, Mary Lou;
Herndon, James E 2nd

Publication type:

journal article

Variation in Oral Board Examination Accommodations Among Specialties.

Published in:

JAMA Network Open, 2024, v. 7, n. 1, p. e2410127, doi. 10.1001/jamanetworkopen.2024.10127

By:

Rowe, Dana G.;
Charles, Antoinette J.;
Luo, Emily J.;
Arango, Alissa M.;
Herndon II, James E.;
Hockenberry, Harrison;
Shortell, Cynthia K.;
Goodwin, C. Rory;
Erickson, Melissa M.

Publication type:

Article

Adjuvant Radiation in Older Patients With Glioblastoma: A Retrospective Single Institution Analysis.

Published in:

Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.631618

By:

Lee, Jessica W.;
Kirkpatrick, John P.;
McSherry, Frances;
Herndon II, James E.;
Lipp, Eric S.;
Desjardins, Annick;
Randazzo, Dina M.;
Friedman, Henry S.;
Ashley, David M.;
Peters, Katherine B.;
Johnson, Margaret O.

Publication type:

Article

Measuring Disease-Free Survival and Cancer Relapse Using Medicare Claims From CALGB Breast Cancer Trial Participants (Companion to 9344).

Published in:

JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 18, p. 1335, doi. 10.1093/jnci/djj363

By:

Lamont, Elizabeth B.;
Herndon II, James E.;
Weeks, Jane C.;
Henderson, I. Craig;
Earle, Craig C.;
Schilsky, Richard L.;
Christakis, Nicholas A.

Publication type:

Article

Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.

Published in:

2005

By:

Lamont, Elizabeth B.;
Herndon II, James E.;
Weeks, Jane C.;
Hendercon, I. Craig;
Lilenbaum, Rogerio;
Schilsky, Richard L.;
Christakis, Nicholas A.;
Herndon, James E 2nd;
Henderson, I Craig

Publication type:

journal article

Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B.

Published in:

2002

By:

Blackstock, A. William;
Herndon II, James E.;
Paskett, Electra D.;
Perry, Michael C.;
Graziano, Stephen L.;
Muscato, Joseph J.;
Kosty, Michael P.;
Arkeley, Wallace L.;
Holland, Jimmie;
Fleishman, Stewart;
Green, Mark R.;
Herndon, James E 2nd;
Akerley, Wallace L

Publication type:

journal article

Financial toxicity of oral chemotherapy in patients with primary brain tumors.

Published in:

Neuro-Oncology Practice, 2025, v. 12, n. 1, p. 153, doi. 10.1093/nop/npae073

By:

Patel, Mallika P;
Affronti, Mary Lou;
Buckley, Evan D;
Herndon II, James E;
Mackowsky, Emma M;
Johnson, Margaret O;
Peters, Katherine B

Publication type:

Article

EGFRvIII-Specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma.

Published in:

PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0094281

By:

Miao, Hongsheng;
Choi, Bryan D.;
Suryadevara, Carter M.;
Sanchez-Perez, Luis;
Yang, Shicheng;
De Leon, Gabriel;
Sayour, Elias J.;
McLendon, Roger;
Herndon II, James E.;
Healy, Patrick;
Archer, Gary E.;
Bigner, Darell D.;
Johnson, Laura A.;
Sampson, John H.

Publication type:

Article

Myeloablative Temozolomide Enhances CD8+ T-Cell Responses to Vaccine and Is Required for Efficacy against Brain Tumors in Mice.

Published in:

PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0059082

By:

Sanchez-Perez, Luis A.;
Choi, Bryan D.;
Archer, Gary E.;
Cui, Xiuyu;
Flores, Catherine;
Johnson, Laura A.;
Schmittling, Robert J.;
Snyder, David;
Herndon II, James E.;
Bigner, Darell D.;
Mitchell, Duane A.;
Sampson, John H.

Publication type:

Article

Hazard-Rate Analysis and Patterns of Recurrence in Early Stage Melanoma: Moving towards a Rationally Designed Surveillance Strategy.

Published in:

PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0057665

By:

Salama, April K. S.;
de Rosa, Nicole;
Scheri, Randall P.;
Pruitt, Scott K.;
Herndon II, James E.;
Marcello, Jennifer;
Tyler, Douglas S.;
Abernethy, Amy P.

Publication type:

Article

A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma.

Published in:

PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031046

By:

Sampson, John H.;
Schmittling, Robert J.;
Archer, Gary E.;
Congdon, Kendra L.;
Nair, Smita K.;
Reap, Elizabeth A.;
Desjardins, Annick;
Friedman, Allan H.;
Fridman, Henry S.;
Herndon, II, James E.;
Coan, April;
McLendon, Roger E.;
Reardon, David A.;
Vredenburgh, James J.;
Bigner, Darell D.;
Mitchell, Duane A.

Publication type:

Article